220 related articles for article (PubMed ID: 28991261)
1. ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.
Jeong HM; Han J; Lee SH; Park HJ; Lee HJ; Choi JS; Lee YM; Choi YL; Shin YK; Kwon MJ
Oncogenesis; 2017 Oct; 6(10):e389. PubMed ID: 28991261
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient Prognosis.
Lu X; Li R; Wang X; Guo Q; Wang L; Zhou X
Cancer Biother Radiopharm; 2022 Nov; 37(9):850-861. PubMed ID: 34495766
[No Abstract] [Full Text] [Related]
3. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
4. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.
Ishii H; Saitoh M; Sakamoto K; Kondo T; Katoh R; Tanaka S; Motizuki M; Masuyama K; Miyazawa K
J Biol Chem; 2014 Oct; 289(40):27386-99. PubMed ID: 25143390
[TBL] [Abstract][Full Text] [Related]
5. Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.
Zhao Y; Li M; Wu W; Miao W; Liu H
Front Immunol; 2023; 14():1161273. PubMed ID: 37090731
[TBL] [Abstract][Full Text] [Related]
6. High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer.
Deng G; Zhou X; Chen L; Yao Y; Li J; Zhang Y; Luo C; Sun L; Tang J
Cancer Cell Int; 2020; 20():174. PubMed ID: 32467669
[TBL] [Abstract][Full Text] [Related]
7. Role of epithelial splicing regulatory protein 1 in cancer progression.
Kwon MJ
Cancer Cell Int; 2023 Dec; 23(1):331. PubMed ID: 38110955
[TBL] [Abstract][Full Text] [Related]
8. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
Freytag M; Kluth M; Bady E; Hube-Magg C; Makrypidi-Fraune G; Heinzer H; Höflmayer D; Weidemann S; Uhlig R; Huland H; Graefen M; Bernreuther C; Wittmer C; Tsourlakis MC; Minner S; Dum D; Hinsch A; Luebke AM; Simon R; Sauter G; Schlomm T; Möller K
BMC Cancer; 2020 Dec; 20(1):1220. PubMed ID: 33339518
[TBL] [Abstract][Full Text] [Related]
9. A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer.
Elhasnaoui J; Ferrero G; Miano V; Franchitti L; Tarulli I; Coscujuela Tarrero L; Cutrupi S; De Bortoli M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887187
[TBL] [Abstract][Full Text] [Related]
10. Splicing factor
Gökmen-Polar Y; Neelamraju Y; Goswami CP; Gu Y; Gu X; Nallamothu G; Vieth E; Janga SC; Ryan M; Badve SS
EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30665944
[TBL] [Abstract][Full Text] [Related]
11. Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer.
Deloria AJ; Höflmayer D; Kienzl P; Łopatecka J; Sampl S; Klimpfinger M; Braunschmid T; Bastian F; Lu L; Marian B; Stättner S; Holzmann K
Oncotarget; 2016 Nov; 7(45):73800-73816. PubMed ID: 27650542
[TBL] [Abstract][Full Text] [Related]
12. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
Vadlamudi Y; Dey DK; Kang SC
Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
[TBL] [Abstract][Full Text] [Related]
13. Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.
Yao J; Caballero OL; Huang Y; Lin C; Rimoldi D; Behren A; Cebon JS; Hung MC; Weinstein JN; Strausberg RL; Zhao Q
Cancer Immunol Res; 2016 Jun; 4(6):552-61. PubMed ID: 27045022
[TBL] [Abstract][Full Text] [Related]
14. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
Göttgens EL; Span PN; Zegers MM
Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
[TBL] [Abstract][Full Text] [Related]
15. The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.
Warzecha CC; Shen S; Xing Y; Carstens RP
RNA Biol; 2009; 6(5):546-62. PubMed ID: 19829082
[TBL] [Abstract][Full Text] [Related]
16. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition.
Reinke LM; Xu Y; Cheng C
J Biol Chem; 2012 Oct; 287(43):36435-42. PubMed ID: 22961986
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
[TBL] [Abstract][Full Text] [Related]
18. Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients.
Liu X; Wang Q; Song S; Feng M; Wang X; Li L; Liu Y; Shi C
Med Sci Monit; 2021 Jul; 27():e931102. PubMed ID: 34262011
[TBL] [Abstract][Full Text] [Related]
19. Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer.
Jolly MK; Preca BT; Tripathi SC; Jia D; George JT; Hanash SM; Brabletz T; Stemmler MP; Maurer J; Levine H
APL Bioeng; 2018 Sep; 2(3):031908. PubMed ID: 31069317
[TBL] [Abstract][Full Text] [Related]
20. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
Harvey SE; Xu Y; Lin X; Gao XD; Qiu Y; Ahn J; Xiao X; Cheng C
RNA; 2018 Oct; 24(10):1326-1338. PubMed ID: 30042172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
